The US is the bigger Brain Imaging, Biomarkers and NeuroInformatics market: $286 Mn against $12 Mn in 2023, about 23 times as large.
India grows faster: 7.7% a year, against 2.7%. The gap still grows from $273 Mn to $347 Mn by 2033.
Clinical research: 1,708 active trials in the US, 35 in India.
| Measure |  US |  India |
|---|---|---|
| Market size, 2023 | $286 Mn | $12 Mn |
| Market size, 2033 projected | $373 Mn | $26 Mn |
| Growth a year (CAGR) | 2.7% | 7.7% |
| Money added, 2023–2033 | $87 Mn | $14 Mn |
| Share of the world market | 42% | 1.8% |
| Size rank of 24 countries | #1 | #12 |
| Market per person, 2023 | $0.84 | $0.01 |
| Active clinical trials | 1,708 | 35 |
| Full report | US report | India report |
Year by year, 2023 to 2033
US India · values between 2023 and 2033 are projected from the 2023 size and the CAGR.
Quick answers
Which is bigger in Brain Imaging, Biomarkers and NeuroInformatics, US or India?
The US is the bigger Brain Imaging, Biomarkers and NeuroInformatics market: $286 Mn against $12 Mn in 2023, about 23 times as large.
Which grows faster in Brain Imaging, Biomarkers and NeuroInformatics, US or India?
India grows faster: 7.7% a year, against 2.7%. The gap still grows from $273 Mn to $347 Mn by 2033.
More Brain Imaging, Biomarkers and NeuroInformatics comparisons
Sources: market size and growth: Acuitas Health Analytics research (2023 base year, forecasts to 2033). Trials: ClinicalTrials.gov (fetched 10 Nov 2026); found by search words, so counts are a guide. Population: World Bank.